1162676-68-7

Upstream product

• 1219496-53-3 2-(3-fluoro-4-nitro-phenoxy)-2-methyl-propionic acid ethyl ester 
• 394-41-2 3-fluoro-4-nitrophenol 
• 600-00-0 ethyl 2-bromoisobutyrate 

Downstream Products

• 1335213-22-3 2-(4-{2-[2-(4-chloro-phenyl)-2,4,5,6,7,8-hexahydro-cycloheptapyrazol-3-yl]-2-cyclohexyl-acetylamino}-3-fluoro-phenoxy)-2-methyl-propionic acid ethyl ester 
• 1162676-63-2 2-(4-{2-[2-(4-chloro-phenyl)-5,6-difluoro-benzoimidazol-1-yl]-2-cyclohexyl-acetylamino}-3-fluoro-phenoxy)-2-methyl-propionic acid ethyl ester 

Relevant academic research and scientific papers

CYCLOPENTYL- AND CYCLOHEPTYLPYRAZOLES

This invention relates to novel cyclopentyl- and cycloheptylpyrazole derivatives of the formula I wherein A and R1 to R4 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. The in

CYCLOPENTYL - AND CYCLOHEPTYLPYRAZOLES AS FXR MODULATORS

This invention relates to novel cyclopentyl- and cycloheptylpyrazole derivatives of the formula (I) wherein A and R1 to R4 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof, to c

INDAZOLE OR 4,5,6,7-TETRAHYDRO-INDAZOLE DERIVATIVES

This invention relates to novel indazole or 4,5,6,7-tetrahydro-indazole derivatives of formula I wherein R1 to R8 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compoun